Oxford Finance

Southlake Biotech Renibus Therapeutics Garners $33M in Bridge Financing

by | Dec 8, 2022
Southlake-based Renibus Therapeutics—a clinical-stage biotech company developing innovative products for cardiorenal diseases—has received $33 million in bridge financing to help it advance three drugs in its pipeline. The drugs are currently in various phases of trials.
MORE